oral semaglutide cardiovascular outcomes soul trial results 2024 2025 Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease Oral semaglutide reduces risk of

compound patent on semaglutide expires in December 2031

No, the FDA does not give FDA approval to any drugs that are made by mixing or changing drugs, like compounded semaglutide for weight loss

Patients may need to resume semaglutide cautiously, with close monitoring

It is also less consistently absorbed and based on the data available it is probably not as effective in terms of sugar lowering or weight loss

Sick-day rules: If you're unwell with vomiting or diarrhoea, maintain fluid intake and seek medical advice if unable to eat or drink for more than 24 hours

A recent study published in Diabetes Obesity and Metabolism found that individuals using these medications lost significant amounts of fat but also experienced some degree of muscle loss, with lean body mass reductions making up approximately 25%40% of total weight Trusted Source Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Neeland IJ, Linge J, Birkenfeld AL Go to Source loss